Albion VC

Albion VC is the technology investment arm of Albion Capital Group LLP, a London-based investment firm founded in 1996. The firm manages approximately £1 billion in venture assets, currently invested in more than 50 active portfolio companies, and has completed more than 100 exits across its lifetime including 4 IPOs and 25 acquisitions. Albion VC invests from seed through Series B in UK-based companies, with a current focus on B2B software, fintech, healthtech, AI, and digital risk, and takes an active, long-term partnership approach with founders. The firm was among the earliest institutional backers of Booking.com, and more recent confirmed investments include Egress (enterprise data security), Quantexa (contextual intelligence for financial crime detection), and Oviva (digital diabetes care). The firm has 116 portfolio companies in total, including one unicorn, four companies that have completed IPOs, and more than 25 acquisitions. As a Venture Capital Trust (VCT) manager regulated by the Financial Conduct Authority, Albion Capital operates a distinct tax-advantaged funding structure common among UK early-stage investors. Recent investments include Flok Health (AI physiotherapy clinics), Bound (cross-border FX risk management), Firenzegroup (Lombard lending), and Tem Energy (AI-powered energy trading). The original directory lists Depop, Secret Escapes, Kano, and Realeyes as portfolio companies, which appear to reflect the firm's earlier, broader consumer investment mandate before the current B2B software and healthtech focus took hold.